South Korea To Join U.S., U.K., Japan With New Bird Flu Vaccine
This article was originally published in PharmAsia News
Executive Summary
A South Korean veterinary professor says he has developed a vaccine for humans to guard against avian influenza to add to those developed in three other countries. The Chungnam National University professor said he developed the CNUK-H5N1-08-01 vaccine with a gene recombination technique to reduce the H5N1 toxicity. Along with the United States, the United Kingdom and Japan, South Korea now can produce a vaccine for people immune to existing vaccines. (Click here for more
You may also be interested in...
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.